• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2大剂量疗法可导致所有具有自然杀伤活性的淋巴细胞亚群从外周血中立即选择性消失:细胞与内皮细胞黏附的作用。

Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.

作者信息

Salvo G, Samoggia P, Masciulli R, Boccoli G, Allavena P, Mariani G, Bullo A, Montesoro E, Bulgarini D, Carlini P

机构信息

Department of Hematology and Oncology, Istituto Superiore di Sanità, Rome, Italy.

出版信息

Eur J Cancer. 1992;28A(4-5):818-25. doi: 10.1016/0959-8049(92)90122-i.

DOI:10.1016/0959-8049(92)90122-i
PMID:1524901
Abstract

As early as 10-15 min after the start of a 30 min interleukin-2 (IL-2) infusion, a rapid, virtually complete disappearance of all natural killer (NK) lymphocyte subpopulations (including both CD3- CD56+ and CD3+ CD56+ cells with either alpha/beta or gamma/delta T-cell receptor) was observed from peripheral blood. In contrast, the number of T lymphocytes (CD3+ CD56-) was unmodified for at least 2 h after IL-2 injection. The IL-2-induced, rapid disappearance from peripheral blood of NK and NK-like lymphocytes may be related to their massive adherence to the activated endothelium. In this regard, IL-2 infusion caused a very rapid rise of tumour necrosis factor-alpha (TNF-alpha) plasma concentration, whereas other cytokines, such as interferon-gamma (IFN-gamma), were induced only at later times. In vitro experiments indicated that IL-2, either alone or better combined with TNF-alpha, exerts a rapid and selective stimulatory effect on NK adhesion to endothelial cells. On the basis of these findings, we suggest that the activation of NK lymphocytes induced by IL-2, alone or combined with TNF-alpha, plays a key role in mediating the massive and selective adherence of NK and NK-like cells following IL-2 bolus infusion.

摘要

早在白细胞介素-2(IL-2)输注30分钟开始后的10 - 15分钟,外周血中所有自然杀伤(NK)淋巴细胞亚群(包括具有α/β或γ/δ T细胞受体的CD3 - CD56 +和CD3 + CD56 +细胞)迅速且几乎完全消失。相比之下,T淋巴细胞(CD3 + CD56 -)的数量在注射IL-2后至少2小时内未发生改变。IL-2诱导的NK和NK样淋巴细胞从外周血中迅速消失可能与其大量黏附于活化的内皮细胞有关。在这方面,IL-2输注导致肿瘤坏死因子-α(TNF-α)血浆浓度迅速升高,而其他细胞因子,如干扰素-γ(IFN-γ),仅在稍后时间被诱导产生。体外实验表明,IL-2单独或与TNF-α联合使用时,对NK细胞黏附于内皮细胞具有快速且选择性的刺激作用。基于这些发现,我们认为IL-2单独或与TNF-α联合诱导的NK淋巴细胞活化在介导IL-2推注后NK和NK样细胞的大量选择性黏附中起关键作用。

相似文献

1
Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: role of cell adhesion to endothelium.白细胞介素-2大剂量疗法可导致所有具有自然杀伤活性的淋巴细胞亚群从外周血中立即选择性消失:细胞与内皮细胞黏附的作用。
Eur J Cancer. 1992;28A(4-5):818-25. doi: 10.1016/0959-8049(92)90122-i.
2
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.α干扰素+白细胞介素-2预处理患者外周血单个核细胞中,肿瘤坏死因子α增强高剂量白细胞介素-2诱导的自然杀伤细胞和淋巴因子激活的杀伤细胞功能。
Eur Cytokine Netw. 1990 Oct-Nov;1(4):221-7.
3
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.高剂量α-2b干扰素与白细胞介素-2大剂量推注隔日交替给药治疗转移性肾细胞癌:一项II期研究
Cancer. 1993 Sep 1;72(5):1733-42. doi: 10.1002/1097-0142(19930901)72:5<1733::aid-cncr2820720537>3.0.co;2-x.
4
Natural immune reactivity-associated therapeutic response in patients with metastatic renal cell carcinoma receiving tumor-infiltrating lymphocytes and interleukin-2-based therapy.接受肿瘤浸润淋巴细胞和白细胞介素-2 疗法的转移性肾细胞癌患者的自然免疫反应相关治疗反应
J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):149-61. doi: 10.1097/00002371-199603000-00008.
5
Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma.白细胞介素2和干扰素2α治疗复发性肾细胞癌和恶性黑色素瘤期间免疫参数的变化
Eur J Surg Oncol. 1993 Jun;19(3):265-72.
6
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.白细胞介素-4作为单一药物或与白细胞介素-2联合使用,对经α-干扰素+白细胞介素-2疗法体内预激活的外周血单个核细胞所诱导的功能和表型改变。
Eur Cytokine Netw. 1990 Aug-Sep;1(3):141-7.
7
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.用于肾细胞癌(RCC)和转移性黑色素瘤过继性治疗的肿瘤浸润淋巴细胞研究:肾细胞癌中细胞毒性自然杀伤细胞和非细胞毒性T细胞的序贯增殖
J Immunother (1991). 1991 Oct;10(5):313-25. doi: 10.1097/00002371-199110000-00003.
8
Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.在接受重组白细胞介素2治疗的癌症患者中鉴定出一种新型CD56阴性淋巴因子激活的杀伤细胞前体。
Cancer Res. 1992 Nov 15;52(22):6318-22.
9
Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.白细胞介素-2和白细胞介素-15对人自然杀伤细胞和自然杀伤受体阳性T细胞的选择性扩增及部分激活
J Immunol. 2001 Sep 15;167(6):3129-38. doi: 10.4049/jimmunol.167.6.3129.
10
Modulation of immune parameters in patients with metastatic renal-cell cancer receiving combination immunotherapy (IL-2, IFN alpha and autologous IL-2-activated lymphocytes).接受联合免疫疗法(白细胞介素-2、α干扰素和自体白细胞介素-2激活淋巴细胞)的转移性肾细胞癌患者免疫参数的调节
Int J Cancer. 1996 Jan 17;65(2):152-60. doi: 10.1002/(SICI)1097-0215(19960117)65:2<152::AID-IJC5>3.0.CO;2-Y.

引用本文的文献

1
Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis.自然杀伤细胞疗法和雾化白细胞介素-2 治疗骨肉瘤肺转移。
Pediatr Blood Cancer. 2014 Apr;61(4):618-26. doi: 10.1002/pbc.24801. Epub 2013 Oct 18.
2
IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.IL-2 刺激而非未刺激的 NK 细胞诱导外周血细胞的选择性消失:一项 I/II 期研究的伴随结果。
PLoS One. 2011;6(11):e27351. doi: 10.1371/journal.pone.0027351. Epub 2011 Nov 9.
3
Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.
在一项I期临床研究中接受重组人白细胞介素-6(IL-6)治疗的患者的免疫功能:C反应蛋白和IgE的诱导以及自然杀伤细胞和淋巴因子激活的杀伤细胞活性的抑制。
Cancer Immunol Immunother. 1994 Feb;38(2):119-26. doi: 10.1007/BF01526207.
4
The immunobiological effects of interleukin-2 in vivo.白细胞介素-2在体内的免疫生物学效应。
Cancer Immunol Immunother. 1994 Oct;39(4):207-16. doi: 10.1007/BF01525983.
5
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.白细胞介素-2。其药理学特性及在癌症患者中的治疗应用综述。
Drugs. 1993 Sep;46(3):446-514. doi: 10.2165/00003495-199346030-00009.